Literature DB >> 9625273

Interaction between grapefruit juice and diazepam in humans.

M Ozdemir1, Y Aktan, B S Boydag, M I Cingi, A Musmul.   

Abstract

Grapefruit juice has been reported to markedly improve the bioavailability of triazolam, midazolam, terfenadine, cyclosporine and several dihydropyridine calcium channel blockers including felodipine, nifedipine, nitrendipine and nisoldipine. Because these drugs are metabolized by the hepatic cytochrome P450 isozyme (CYP) 3A4, the inhibitory effect of grapefruit juice is thought to results from inhibition of CYP3A4. In this study, our aim was to investigate the effects of grapefruit juice on plasma concentrations of diazepam. Eight healthy male and female subjects participated in this study. Oral (5 mg) diazepam was administered with either 250 ml water and grapefruit juice. Blood samples were collected for a 24 h period, and whole blood concentrations of diazepam were measured enzyme immunoassay. The mean AUC(0-24) of diazepam was increased 3.2-fold (P < 0.001) and Cmax was increased 1.5-fold (P < 0.05) by the grapefruit juice. Grapefruit juice postponed the tmax of diazepam from 1.50 h to 2.06 h (P < 0.01).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9625273     DOI: 10.1007/BF03189827

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.569


  24 in total

1.  In vitro inhibition of dihydropyridine oxidation and aflatoxin B1 activation in human liver microsomes by naringenin and other flavonoids.

Authors:  F P Guengerich; D H Kim
Journal:  Carcinogenesis       Date:  1990-12       Impact factor: 4.944

2.  Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 IIIA4.

Authors:  F P Guengerich; W R Brian; M Iwasaki; M A Sari; C Bäärnhielm; P Berntsson
Journal:  J Med Chem       Date:  1991-06       Impact factor: 7.446

3.  Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers.

Authors:  U Merkel; H Sigusch; A Hoffmann
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

4.  Inhibitory effect of grapefruit juice and its bitter principal, naringenin, on CYP1A2 dependent metabolism of caffeine in man.

Authors:  U Fuhr; K Klittich; A H Staib
Journal:  Br J Clin Pharmacol       Date:  1993-04       Impact factor: 4.335

5.  The effect of grapefruit juice on cyclosporine and prednisone metabolism in transplant patients.

Authors:  A A Hollander; J van Rooij; G W Lentjes; F Arbouw; J B van Bree; R C Schoemaker; L A van Es; F J van der Woude; A F Cohen
Journal:  Clin Pharmacol Ther       Date:  1995-03       Impact factor: 6.875

6.  Grapefruit juice and cimetidine inhibit stereoselective metabolism of nitrendipine in humans.

Authors:  P A Soons; B A Vogels; M C Roosemalen; H C Schoemaker; E Uchida; B Edgar; J Lundahl; A F Cohen; D D Breimer
Journal:  Clin Pharmacol Ther       Date:  1991-10       Impact factor: 6.875

7.  Cytochrome P 450 isoenzymes, epoxide hydrolase and glutathione transferases in rat and human hepatic and extrahepatic tissues.

Authors:  I de Waziers; P H Cugnenc; C S Yang; J P Leroux; P H Beaune
Journal:  J Pharmacol Exp Ther       Date:  1990-04       Impact factor: 4.030

8.  Influence of grapefruit juice on the pharmacokinetics of a slow release nifedipine formulation.

Authors:  H Sigusch; M Hippius; L Henschel; K Kaufmann; A Hoffmann
Journal:  Pharmazie       Date:  1994-07       Impact factor: 1.267

9.  Taxol metabolism by human liver microsomes: identification of cytochrome P450 isozymes involved in its biotransformation.

Authors:  T Cresteil; B Monsarrat; P Alvinerie; J M Tréluyer; I Vieira; M Wright
Journal:  Cancer Res       Date:  1994-01-15       Impact factor: 12.701

10.  Grapefruit juice alters terfenadine pharmacokinetics, resulting in prolongation of repolarization on the electrocardiogram.

Authors:  R E Benton; P K Honig; K Zamani; L R Cantilena; R L Woosley
Journal:  Clin Pharmacol Ther       Date:  1996-04       Impact factor: 6.875

View more
  8 in total

1.  Pharmacokinetic analysis of felodipine-grapefruit juice interaction based on an irreversible enzyme inhibition model.

Authors:  H Takanaga; A Ohnishi; H Matsuo; H Murakami; H Sata; K Kuroda; A Urae; S Higuchi; Y Sawada
Journal:  Br J Clin Pharmacol       Date:  2000-01       Impact factor: 4.335

2.  S-ketamine concentrations are greatly increased by grapefruit juice.

Authors:  Marko A Peltoniemi; Teijo I Saari; Nora M Hagelberg; Kari Laine; Pertti J Neuvonen; Klaus T Olkkola
Journal:  Eur J Clin Pharmacol       Date:  2012-06       Impact factor: 2.953

Review 3.  Undesirable effects of citrus juice on the pharmacokinetics of drugs: focus on recent studies.

Authors:  Mitsuo Saito; Mutsuko Hirata-Koizumi; Mariko Matsumoto; Tsutomu Urano; Ryuichi Hasegawa
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

4.  Effect of furanocoumarin derivatives in grapefruit juice on the uptake of vinblastine by Caco-2 cells and on the activity of cytochrome P450 3A4.

Authors:  A Ohnishi; H Matsuo; S Yamada; H Takanaga; S Morimoto; Y Shoyama; H Ohtani; Y Sawada
Journal:  Br J Pharmacol       Date:  2000-07       Impact factor: 8.739

Review 5.  Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition.

Authors:  G K Dresser; J D Spence; D G Bailey
Journal:  Clin Pharmacokinet       Date:  2000-01       Impact factor: 6.447

Review 6.  The effect of grapefruit juice on drug disposition.

Authors:  Michael J Hanley; Paul Cancalon; Wilbur W Widmer; David J Greenblatt
Journal:  Expert Opin Drug Metab Toxicol       Date:  2011-01-22       Impact factor: 4.481

Review 7.  Grapefruit-drug interactions.

Authors:  Kay Seden; Laura Dickinson; Saye Khoo; David Back
Journal:  Drugs       Date:  2010-12-24       Impact factor: 9.546

Review 8.  Effects of food on clinical pharmacokinetics.

Authors:  B N Singh
Journal:  Clin Pharmacokinet       Date:  1999-09       Impact factor: 6.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.